Insmed Inc at Goldman Sachs Healthcare Conference Transcript
Perfect. Thanks, everyone, for joining us. Andrea Tan, biotech analyst at Goldman Sachs. She we're pleased to have Will Lewis, CEO of Insmed with us. Thanks again, Will, for joining us.
Glad to be here.
Questions & Answers
Maybe if we can start big picture. Insmed, 4 pillars, very, very active. Maybe walk us through a high-level overview of each of those pillars, the progress you're making there and then the expectations for these key data reads that are coming from each one.
Sure. I think the next 12 months is probably the most exciting time in the history of the company, and I've been at the company now coming up on 11 years. We've really spent the last several years
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
